CBT Stock Analysis: Cabot | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 4.522m USD | 12M Return: 8.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 52.7M
EPS Trend: 78.2%
Qual. Beats: 2
Rev. Trend: -84.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cabot Corporation is a U.S.-based specialty chemicals and performance materials company operating through two segments: Reinforcement Materials and Performance Chemicals. Its Reinforcement Materials business centers on carbon black, a petroleum-derived feedstock that serves as the primary reinforcing filler in rubber compounds, with the global tire industry as its dominant end-market. The Performance Chemicals segment supplies higher-value specialty carbons, fumed silica, fumed alumina, aerogels, masterbatches, conductive compounds, inkjet colorants, and carbon nanotubes to industrial customers.
Cabots products are used across tires, industrial rubber goods, lithium-ion and lead-acid batteries for electric vehicles, inks, coatings, adhesives, cosmetics, and pharmaceuticals. Distribution is handled globally through sales representatives and distributors spanning the Americas, Europe, the Middle East, Africa, and Asia Pacific. Founded in 1882 and headquartered in Boston, Massachusetts, the company is listed on the NYSE under the ticker CBT and is classified within the Materials sector, specifically the Commodity Chemicals sub-industry.
- Tire reinforcement demand tracks global auto and replacement tire cycles
- EV battery adoption lifts conductive additives volume and pricing
- Energy and feedstock costs pressure specialty chemicals margins
| Net Income: 285.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 4.17 > 1.0 |
| NWC/Revenue: 13.40% < 20% (prev 20.09%; Δ -6.69% < -1%) |
| CFO/TA 0.17 > 3% & CFO 671.0m > Net Income 285.0m |
| Net Debt (1.13b) to EBITDA (755.0m): 1.50 < 3 |
| Current Ratio: 1.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.2m) vs 12m ago -4.04% < -2% |
| Gross Margin: 24.95% > 18% (prev 24.87%; Δ 0.08% > 0.5%) |
| Asset Turnover: 93.09% > 50% (prev 103.3%; Δ -10.19% > 0%) |
| Interest Coverage Ratio: 7.71 > 6 (EBIT TTM 586.0m / Interest Expense TTM 76.0m) |
| A: 0.12 (Total Current Assets 1.55b - Total Current Liabilities 1.07b) / Total Assets 3.90b |
| B: 0.47 (Retained Earnings 1.83b / Total Assets 3.90b) |
| C: 0.15 (EBIT TTM 586.0m / Avg Total Assets 3.84b) |
| D: 0.71 (Book Value of Equity 1.57b / Total Liabilities 2.21b) |
| Altman-Z'' = 4.11 = AA |
| DSRI: 0.97 (Receivables 657.0m/739.0m, Revenue 3.58b/3.91b) |
| GMI: 1.00 (GM 24.87% / 24.95%) |
| AQI: 1.01 (AQ_t 0.15 / AQ_t-1 0.15) |
| SGI: 0.91 (Revenue 3.58b / 3.91b) |
| TATA: -0.10 (NI 285.0m - CFO 671.0m) / TA 3.90b) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of July 09, 2026, the stock is trading at USD 82.90 with a total of 985,911 shares traded. Over the past week, the price has changed by -8.72%, over one month by -0.02%, over three months by +9.17% and over the past year by +8.33%.
Current recommended Stop Loss: 79.30 (which is 4.3% or 1.3 ATR below the current price).
Cabot has received a consensus analysts rating of 3.60. Therefore, it is recommended to hold CBT.
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 88.5 | 6.8% |
P/E Trailing = 16.5283
P/E Forward = 10.6157
P/S = 1.2649
P/B = 2.8428
P/EG = 1.0017
Revenue TTM = 3.58b USD
EBIT TTM = 586.0m USD
EBITDA TTM = 755.0m USD
Long Term Debt = 863.0m USD (from longTermDebt, last quarter)
Short Term Debt = 436.0m USD (from shortTermDebt, last quarter)
Debt = 1.38b USD (from shortLongTermDebtTotal, last quarter) + Leases 85.0m
Net Debt = 1.13b USD (calculated: Debt 1.38b - CCE 252.0m)
Enterprise Value = 5.65b USD (4.52b + Debt 1.38b - CCE 252.0m)
Interest Coverage Ratio = 7.71 (Ebit TTM 586.0m / Interest Expense TTM 76.0m)
EV/FCF = 12.32x (Enterprise Value 5.65b / FCF TTM 459.0m)
FCF Yield = 8.12% (FCF TTM 459.0m / Enterprise Value 5.65b)
FCF Margin = 12.84% (FCF TTM 459.0m / Revenue TTM 3.58b)
Net Margin = 7.97% (Net Income TTM 285.0m / Revenue TTM 3.58b)
Gross Margin = 24.95% ((Revenue TTM 3.58b - Cost of Revenue TTM 2.68b) / Revenue TTM)
Gross Margin QoQ = 24.00% (prev 24.85%)
Tobins Q-Ratio = 1.45 (Enterprise Value 5.65b / Total Assets 3.90b)
Interest Expense / Debt = 5.49% (Interest Expense 76.0m / Debt 1.38b)
Taxrate = 36.38% (187.0m / 514.0m)
NOPAT = 372.8m (EBIT 586.0m * (1 - 36.38%))
Current Ratio = 1.45 (Total Current Assets 1.55b / Total Current Liabilities 1.07b)
Debt / Equity = 0.88 (Debt 1.38b / totalStockholderEquity, last quarter 1.57b)
Debt / EBITDA = 1.50 (Net Debt 1.13b / EBITDA 755.0m)
Debt / FCF = 2.47 (Net Debt 1.13b / FCF TTM 459.0m)
Total Stockholder Equity = 1.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.42% (Net Income 285.0m / Total Assets 3.90b)
RoE = 18.29% (Net Income TTM 285.0m / Total Stockholder Equity 1.56b)
RoCE = 24.20% (EBIT 586.0m / Capital Employed (Equity 1.56b + L.T.Debt 863.0m))
RoIC = 12.08% (NOPAT 372.8m / Invested Capital 3.09b)
WACC = 7.59% (E(4.52b)/V(5.91b) * Re(8.84%) + D(1.38b)/V(5.91b) * Rd(5.49%) * (1-Tc(0.36)))
Discount Rate = 8.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -2.92%
[DCF] Terminal Value 77.97% ; FCFF base≈390.6m ; Y1≈447.8m ; Y5≈659.0m
[DCF] Fair Price = 170.2 (EV 9.92b - Net Debt 1.13b = Equity 8.78b / Shares 51.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 78.18 | EPS CAGR: 10.89% | SUE: 1.82 | # QB: 2
Revenue Correlation: -84.15 | Revenue CAGR: -3.80% | SUE: -0.31 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.65 | Chg30d=+2.19% | Revisions=-17% | Analysts=6
EPS current Year (2026-09-30): EPS=6.32 | Chg30d=+0.91% | Revisions=+17% | GrowthEPS=-12.9% | GrowthRev=-3.0%
EPS next Year (2027-09-30): EPS=7.00 | Chg30d=+1.01% | Revisions=+50% | GrowthEPS=+10.8% | GrowthRev=+3.3%
[Analyst] Revisions Ratio: +25% (up=6, down=3)